- Home
- THTX vs CRVO Comparison
THTX vs CRVO Comparison
Compare THTX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- CRVO
- Stock Information
- Founded
- THTX 1993
- CRVO 2001
- Country
- THTX Canada
- CRVO United States
- Employees
- THTX N/A
- CRVO N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- CRVO Health Care
- Exchange
- THTX Nasdaq
- CRVO Nasdaq
- Market Cap
- THTX 118.2M
- CRVO 95.4M
- IPO Year
- THTX N/A
- CRVO N/A
- Fundamental
- Price
- THTX $2.62
- CRVO $8.49
- Analyst Decision
- THTX Hold
- CRVO Strong Buy
- Analyst Count
- THTX 1
- CRVO 8
- Target Price
- THTX N/A
- CRVO $25.43
- AVG Volume (30 Days)
- THTX 6.2M
- CRVO 453.1K
- Earning Date
- THTX 04-09-2025
- CRVO 05-20-2025
- Dividend Yield
- THTX N/A
- CRVO N/A
- EPS Growth
- THTX N/A
- CRVO N/A
- EPS
- THTX N/A
- CRVO N/A
- Revenue
- THTX $88,666,000.00
- CRVO $9,737,974.00
- Revenue This Year
- THTX N/A
- CRVO N/A
- Revenue Next Year
- THTX $15.13
- CRVO N/A
- P/E Ratio
- THTX N/A
- CRVO N/A
- Revenue Growth
- THTX 13.52
- CRVO 36.29
- 52 Week Low
- THTX $1.08
- CRVO $1.80
- 52 Week High
- THTX $3.13
- CRVO $25.69
- Technical
- Relative Strength Index (RSI)
- THTX 57.56
- CRVO 46.29
- Support Level
- THTX $2.64
- CRVO $8.40
- Resistance Level
- THTX $2.82
- CRVO $11.79
- Average True Range (ATR)
- THTX 0.17
- CRVO 0.99
- MACD
- THTX -0.04
- CRVO -0.19
- Stochastic Oscillator
- THTX 20.45
- CRVO 10.45
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.